NCT01495676 2025-10-10
GETUGV04
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Terminated
Clinical Trials
16 trialsNCT04806334 2024-04-18
Radiogenomics of Muscle Invasive Bladder Cancer
Cedars-Sinai Medical Center
Phase NA Terminated
NCT04779489 2024-02-06
CIRTiN-BC
University of Texas Southwestern Medical Center
Phase NA Terminated
NCT03718741 2022-05-09
Bladder-Aid
Istituto Clinico Humanitas
Phase NA Terminated
NCT01954173 2022-03-02
Adjuvant Radiation for High Risk Bladder Cancer
Emory University
Phase NA Terminated
NCT04273724 2021-10-18
Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer
UNC Lineberger Comprehensive Cancer Center
Phase NA Terminated
NCT00350688 2020-04-17
Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy
Ottawa Hospital Research Institute
Phase NA Terminated
NCT03986398 2020-04-08
Cranberry
Hopital Foch
Phase NA Terminated
NCT02365207 2019-11-05
Intravesical BCG Administration to Patients With Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase NA Terminated
NCT02202044 2019-06-14
Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection
University of Colorado, Denver
Phase NA Terminated
NCT02145390 2018-08-28
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
University of Miami
Phase NA Terminated
NCT02700724 2018-08-13
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
Vanderbilt University Medical Center
Phase NA Terminated
NCT01108003 2017-06-26
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Roswell Park Cancer Institute
Phase NA Terminated
NCT00802633 2014-02-11
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Vanderbilt University
Phase NA Terminated
NCT01010334 2013-08-14
Comparison of Standard of Care or Treatment on Protocol
New Mexico Cancer Research Alliance
Phase NA Terminated
NCT00147238 2012-08-07
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
M.D. Anderson Cancer Center
Phase NA Terminated